112 related articles for article (PubMed ID: 9037269)
1. Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients.
Paya CV
Transplant Proc; 1996 Dec; 28(6 Suppl 2):9-11. PubMed ID: 9037269
[No Abstract] [Full Text] [Related]
2. [Prophylaxis of cytomegalovirus infection in the transplant recipient].
Aguado JM; Lumbreras C; Otero JR
Med Clin (Barc); 1992 Oct; 99(11):430-4. PubMed ID: 1335103
[No Abstract] [Full Text] [Related]
3. Cytomegalovirus prophylaxis strategies in high-risk transplantation.
Snydman DR
Transplant Proc; 1994 Oct; 26(5 Suppl 1):20-2. PubMed ID: 7940971
[No Abstract] [Full Text] [Related]
4. Prevention of cytomegalovirus disease in transplant recipients.
Pidgeon GB; Bailey RR
N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
[No Abstract] [Full Text] [Related]
5. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
Singh N
Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
[TBL] [Abstract][Full Text] [Related]
6. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
Singh N
Clin Infect Dis; 2005 Mar; 40(5):704-8. PubMed ID: 15714416
[No Abstract] [Full Text] [Related]
7. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
8. Combination antiviral strategies in managing cytomegalovirus infection.
Martin M
Transplant Proc; 1994 Oct; 26(5 Suppl 1):28-30. PubMed ID: 7940973
[No Abstract] [Full Text] [Related]
9. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of cytomegalovirus in organ transplantation].
Aguado JM
Rev Clin Esp; 1996 Apr; 196(4):240-7. PubMed ID: 8701064
[No Abstract] [Full Text] [Related]
11. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
[TBL] [Abstract][Full Text] [Related]
12. Optimization of outcomes related to cytomegalovirus in organ transplant recipients.
Singh N
Transplantation; 2006 Jul; 82(1):15-6. PubMed ID: 16861935
[No Abstract] [Full Text] [Related]
13. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan PR; Pascual M
Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
[No Abstract] [Full Text] [Related]
14. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
15. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
Snydman DR
Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
[No Abstract] [Full Text] [Related]
16. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
Pescovitz MD
Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with intravenous immune globulin.
Snydman DR
Transplant Proc; 1991 Apr; 23(2 Suppl 1):20-5. PubMed ID: 1647560
[No Abstract] [Full Text] [Related]
18. The case for cytomegalovirus prophylaxis in solid organ transplantation.
Snydman DR
Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
[TBL] [Abstract][Full Text] [Related]
19. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in seromismatched lung transplant recipients with and without prophylaxis with CMV immunoglobulin.
Kathawalla SA; Stillwell PC; Gordon S; Haug M; Perl M; Arroliga AC; Mehta AC; Avery R; Kirby T
Transplant Proc; 1996 Dec; 28(6 Suppl 2):16. PubMed ID: 9037272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
